Bladder Cancer technology: New improved Blue Light Cystoscopy system receives FDA approval for use in NMIBC in the U.S.

OSLO, Norway, Feb. 7, 2022 /PRNewswire/ — Photocure ASA, The Bladder Cancer Company, announces U.S. Food and Drug Administration (FDA) approval of a new and improved Blue Light system to be used with Photocure’s Cysview® product in Blue Light Cystoscopy (BLC®) procedures for the…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.